Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,066,771
+$598,009 QoQ
Shares Held
19,515
+6.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#672
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $142,928,858 across 9 Drug Manufacturers - General names. AMGN ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,270 | $78,286,802 | |
| 2 | ABBV |
AbbVie Inc.
|
62,362 | $15,692,773 | |
| 3 | JNJ |
Johnson & Johnson
|
59,384 | $15,081,754 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,897 | $11,294,764 | |
| 5 | AMGN |
Amgen Inc
This page
|
19,515 | $7,066,771 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
44,792 | $5,659,021 | |
| 7 | PFE |
Pfizer Inc
|
199,117 | $4,794,737 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
69,612 | $4,011,043 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,066,771 | 19,515 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,468,762 | 18,385 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $6,240,165 | 19,065 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $6,348,089 | 22,495 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $6,280,828 | 22,495 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $7,495,893 | 24,060 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $6,429,988 | 24,670 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $7,008,067 | 21,750 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,170,727 | 22,950 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,198,176 | 21,800 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,019,618 | 20,900 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,503,992 | 24,200 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $5,461,692 | 24,600 | Shares | Sole | 2024-04-05 | |
| 2023-03-31 | $5,826,175 | 24,100 | Shares | Sole | 2024-04-05 | |
| 2022-12-31 | $5,961,928 | 22,700 | Shares | Sole | 2024-04-05 | |
| 2022-09-30 | $5,296,900 | 23,500 | Shares | Sole | 2024-04-05 | |
| 2022-06-30 | $6,033,840 | 24,800 | Shares | Sole | 2024-04-05 | |
| 2022-03-31 | $6,311,502 | 26,100 | Shares | Sole | 2024-04-05 | |
| 2021-12-31 | $6,231,669 | 27,700 | Shares | Sole | 2024-04-05 | |
| 2021-09-30 | $5,592,695 | 26,300 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $6,093,750 | 25,000 | Shares | Sole | 2024-04-05 | |
| 2021-03-31 | $5,672,868 | 22,800 | Shares | Sole | 2024-04-05 | |
| 2020-12-31 | $5,954,928 | 25,900 | Shares | Sole | 2024-04-05 | |
| 2020-09-30 | $6,150,672 | 24,200 | Shares | Sole | 2024-04-05 | |
| 2020-06-30 | $5,306,850 | 22,500 | Shares | Sole | 2024-04-05 | |
| 2020-03-31 | $4,297,876 | 21,200 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||